Insider buying last 90 days
No open-market insider purchases were filed for NICE in the last 90 days.
From Form 4 filings, dated to when each was filed.
NICE moved this week on third-quarter results and a round of analyst reaction. The company exceeded its revenue and adjusted EPS guidance, with total revenue up 8% year-over-year to $790.7 million and non-GAAP EPS of $2.84, and raised its full-year 2026 non-GAAP EPS guidance to $11.12–$11.32, helped by AI annual recurring revenue growth of 46% and an expanding CXone backlog. Alongside the raise, NICE announced a 5% workforce reduction tied to a partner-led go-to-market shift. Analyst responses were mixed: Citizens cut its price target to $158 from $170 while keeping a Market Outperform rating, and Morningstar cut its fair value estimate by 20% on doubts about the cloud growth recovery, even as other commentary maintained a Strong Buy view citing resilient growth despite margin compression.
The stock closes at $96.68, down across recent stretches with a one-month return of -17.7% and a one-year return of -23.5%, sitting between its 50-day average of $110.48 and 200-day average of $104.78. The GekkoIndex reads 73.4, placing NICE in the Buying zone. Price sits 46.4% below Gekko Fair Value of $180.46.
Over the next 20 trading days, the next earnings date falls on 18 February 2027, 100 days out and outside this horizon. No insider, Congress or unusual options activity appears in the respective 90-day and 30-day windows. Seasonality from this point in the calendar has averaged a 7% return over 5 years, rising in 4 of them, which is worth noting alongside the current gap to Gekko Fair Value.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
NICE scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
Averages disagree
Close $96.04 sits between the 50-day ($109.42) and 200-day ($104.42) averages, or the averages disagree.
See the chart67.8, Accumulation
Reading 67.8 is in the Accumulation zone.
See the GekkoIndex46.9% below
Price is 46.9% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 95 days
Next report Feb 18, 2027, 95 days away — outside a typical 20-trading-day hold.
See earnings−2.3% on average
From this point in the calendar, the next 20 trading days averaged −2.3% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
NICE closed at $96.04 on Nov 13, 2026, −22.7% over the past year, inside a 52-week range of $83.10 to $136.53.
Use the left and right arrow keys to read daily values.
Put NICE on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
NICE builds cloud software that uses artificial intelligence to help organizations manage customer service and guard against financial crime. Its tools are used by businesses across the United States, Europe, the Middle East, Africa, and the Asia Pacific to automate support interactions, support staff with AI-driven assistance, and bring together enterprise data, knowledge, and customer records in one place. The company is perhaps best recognized for its work helping organizations detect fraud and money laundering in real time.
The company is structured around two areas of focus. One centers on customer engagement, anchored by a platform called CXone Mpower, which unifies service automation and workforce tools. The other addresses financial crime and compliance, offering products such as NICE Actimize, X-Sight, and Xceed, which give financial institutions and smaller organizations ways to detect fraud, verify customer identities, monitor money laundering, and meet capital markets rules. It also provides NICE Evidencentral, a platform used within the criminal justice system for managing digital evidence and investigations.
NICE was incorporated in 1986 and is headquartered in Ra'anana, Israel. Its shares trade under the ticker NICE.
NICE’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 67.8, in the Accumulation zone, down 7.6 points over five sessions.
Down 7.6 points over five sessions, from the Buying zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 54 | +2.1% | −1.0% | ||
| Accumulation (current zone) | 277 | +0.1% | −1.2% | ||
| Neutral | 314 | −1.1% | −2.7% | ||
| Distribution | 10 | −11.4% | −7.1% | ||
| Selling | 0 | Not available | |||
Average NICE share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
NICE trades 46.9% below Gekko Fair Value of $181.01, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what NICE shares are worth, recalculated every trading day.
$181.01
Gekko Fair Value, Nov 14, 2026
46.9% Undervalued
At the end of Aug 2026 the price was 6.0% below the estimate.
No open-market insider purchases were filed for NICE, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for NICE in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in NICE were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
NICE has been buying back its own shares.
From company filings.
NICE reports on Feb 18, 2027 (95 days away), and beat the EPS estimate in 7 of its last 8 reports.
Feb 18, 2027
95 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Nov 4, 2026 | $2.84 est $2.78 | $790.7M est $785.7M | −9.7% |
| Aug 5, 2026 | $1.95 est $2.13 | $782.3M est $766.3M | −6.0% |
| May 6, 2026 | $2.64 est $2.52 | $768.6M est $760.9M | −23.5% |
| Feb 19, 2026 | $3.24 est $3.21 | $786.5M est $780.0M | +19.5% |
| Nov 13, 2025 | $3.18 est $3.17 | $732.0M est $779.9M | +7.3% |
| Aug 14, 2025 | $3.01 est $2.99 | $726.7M est $713.2M | −10.0% |
| May 15, 2025 | $2.87 est $2.84 | $700.2M est $713.1M | −3.6% |
| Feb 20, 2025 | $3.02 est $2.95 | $721.6M est $718.5M | −12.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for NICE is $127.54, +32.8% from the last close, from 6 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 6 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 5 | Morgan Stanley | $115 | +19.7% |
| Nov 5 | Citizens JMP | $158 | +64.5% |
| Nov 5 | Mizuho Securities | $120 | +24.9% |
| Nov 4 | RBC Capital | $130 | +35.4% |
| Sep 30 | Oppenheimer | $150 | +56.2% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, NICE averaged −2.3% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −7.2% | 1 of 5 |
| Next 10 trading days | −6.7% | 1 of 5 |
| Next 15 trading days | −4.1% | 1 of 5 |
| Next 20 trading days | −2.3% | 2 of 5 |
| Next 30 trading days | −4.0% | 1 of 5 |
For scale, NICE’s typical 20-trading-day move in either direction is about 6.9%.
NICE’s market cap is $5.51B, with a P/E ratio of 15.3 and revenue of $3.13B over the last twelve months.
Coverage of NICE this week reads positive: 3 positive, 3 neutral and 1 negative headlines.
NICE’s market cap is $5.51B at the Nov 13, 2026 close of $96.04, with 57.36M shares outstanding. The shares trade on a P/E ratio of 15.3.
The consensus analyst 12-month price target for NICE is $127.54, +32.8% from the last close. Of the 6 firms that rated the stock in the last 90 days, 5 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate NICE is undervalued: the Nov 13, 2026 close of $96.04 is 46.9% below Gekko Fair Value of $181.01. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
NICE is expected to report on Feb 18, 2027 (95 days away). Analysts expect earnings of $3.05 per share on revenue of $836.8M. NICE beat the earnings estimate in 7 of its last 8 reports, moving 11.6% on average across the report.
NICE’s 52-week high is $136.53 and its 52-week low is $83.10; it closed at $96.04 on Nov 13, 2026, −22.7% over the past year. Over the last five years the shares peaked at $319.88 on Nov 15, 2021.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk), 1 as mixed (trend) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.